AzTrials
AzTrials

Muscle Disuse AtrophySTARNCT05097092

Strength Training Augmenting Rehabilitation

A study testing Orthopedic immobilization, Unilateral resistance training and Bilateral resistance training in people with Muscle Disuse Atrophy, run by Texas Christian University at 2 sites in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This project aims to determine whether a novel strength training rehabilitation protocol can diminish the negative consequences of limb immobilization and expedite the restoration of muscle function during retraining in healthy individuals. Read more about this study

Who is it for?
Ages 18 to 35 yearsHealthy volunteers can take part
Conditions the study is for
Muscle Disuse Atrophy
What is being tested?
Orthopedic immobilization, Unilateral resistance training and Bilateral resistance training
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
2 sitesUnited States
Study dates
13 Aug 2021to 14 Aug 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • a body mass index between 18 - 35 kg/m2
  • 18-35 years of age
  • right-hand dominant
  • willingness to comply with the immobilization requirements
  • willingness to refrain from strength training outside of the study
  • willingness to comply with the strength training procedures of the study

Who cannot join

  • a personal or family history of blood clots
  • a personal or family history of thyroid disorders
  • previous orthopedic surgeries to the upper limbs and/or joint pain of the upper limbs in the last 6 months
  • neuromuscular or metabolic disorders
  • osteoarthritis
  • use of hormone replacement therapy (ie., testosterone, estrogen, and/or growth hormone pharmaceuticals)
  • pregnancy and/or nursing

Trial locations and contacts

2 sites in 1 country.

United States2 sites, 2 recruiting
  • TCU Neuromuscular Physiology Laboratory

    Fort Worth, Texas, 76126

    Enrolling by invitation
  • TCU RIC

    Fort Worth, Texas, 76126

    Joshua C Carr, 917-257-6867, joshua.carr@tcu.edu

    Recruiting

Other trials in United States

About this study

Official title: Strength Training Augmenting Rehabilitation - 1

This project aims to determine whether a novel strength training rehabilitation protocol can diminish the negative consequences of limb immobilization and expedite the restoration of muscle function during retraining in healthy individuals.

Read the detailed description

The present study will examine the time course of muscle strength and size adaptations in two groups of volunteers during immobilization and retraining. Both groups will undergo temporary muscle disuse by wearing a shoulder sling and swathe on their non-dominant arm for ~≥10 hours/day for four weeks. One group (immobilization + unilateral training) will perform progressive unilateral strength training of the free limb throughout the immobilization period. The other group (immobilization control) will not undergo any training during the immobilization period. Following immobilization, both groups will undergo four weeks of bilateral strength training to retrain the immobilized arm.

Being tested
Orthopedic immobilization, Unilateral resistance training, Bilateral resistance training
Medical subject headings
Muscular Disorders, Atrophic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Orthopedic immobilizationProcedure or surgery

    Orthopedic immobilization will be performed with a sling and swathe.

  • Unilateral resistance trainingOther

    Unilateral resistance training will be performed by the dominant arm of the immobilization + unilateral resistance training group during Phase 1.

  • Bilateral resistance trainingOther

    Bilateral resistance training will be performed by both arms in both groups during Phase 2.

Study groups in NCT05097092
Study groupRoleWhat they receive
Immobilization controlExperimentalThe immobilization control group will undergo arm immobilization. Immobilization will be implemented with four weeks of muscle unloading with a sling and swathe on the nondominant arm. The sling will suspend the arm at the elbow joint with the elbow in a flexed position at 90°, the swathe will then wrap around the participant to fix the arm against the body.
Receives: Procedure: Orthopedic immobilization; Other: Bilateral resistance training
Immobilization with unilateral trainingExperimentalThe immobilization with unilateral training group will undergo arm immobilization for four with a sling and swathe on the nondominant arm. The sling will suspend the arm at the elbow joint with the elbow in a flexed position at 90°, the swathe will then wrap around the participant to fix the arm against the body. The free (non-immobilzed) arm of this group will undergo heavy strength training twice per week throughout the immobilization period. The training will consist of unilateral dumbbell shoulder press and biceps curl.
Receives: Procedure: Orthopedic immobilization; Other: Unilateral resistance training; Other: Bilateral resistance training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in isometric muscle strength

    MVC (Newton)

    Measured: Changes from baseline at 5 and 10 weeks

  2. Changes in dynamic muscle strength

    1RM (lbs)

    Measured: Changes from baseline at 5 and 10 weeks

  3. Changes in muscle size

    Ultrasound muscle thickness of biceps brachii and triceps brachii

    Measured: Changes from baseline at 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 weeks

  4. Changes in lean mass

    DEXA

    Measured: Changes from baseline at 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 weeks

  5. Changes in EMG amplitude

    Surface EMG

    Measured: Changes from baseline at 5 and 10 weeks

  6. Changes in action potential amplitude

    Surface EMG Decomposition

    Measured: Changes from baseline at 5 and 10 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Oct 2021
  2. Study start13 Aug 2021
  3. Primary completion13 Aug 2023 (estimated)
  4. Study completion14 Aug 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05097092
Sponsor's protocol ID
2021-101
Acronym
STAR
Status last verified
Oct 2021
First submitted
22 Sep 2021
Last updated
27 Oct 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Orthopedic immobilization, Unilateral resistance training and Bilateral resistance training in people with Muscle Disuse Atrophy, run by Texas Christian University at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 27 Oct 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in isometric muscle strength (time frame: Changes from baseline at 5 and 10 weeks). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Oct 2021.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in